About LGC Biosearch Technologies
LGC Biosearch Technologies is a Healthcare company based in Petaluma (United States) founded in 1993. It operates as a provider of genomic analysis tools, instrumentation and services. LGC Biosearch Technologies has completed 1 acquisition, including Lightspeed Genomics. Its website biosearchtech.com draws about 52 thousand monthly visits. LGC Biosearch Technologies offers products and services including Oligos, KASP Genotyping Reagents, PCR Instruments, and Nucleic Acid Extraction Kits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is LUCIGEN CORP. Its competitors include ArcherDX, NuProbe, Nanosphere, ThunderBio Innovation and Gen-Probe and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
LGC Biosearch Technologies was founded in 1993 and is headquartered in Petaluma, United States. Operations focus on the biotechnology sector, where kits and reagents for qPCR, SNP genotyping via dual-labeled probes, molecular beacons, scorpion primers, and calibration dyes are developed. Oligo synthesis and RNA FISH capabilities are also supported. Services encompass GMP manufacturing, custom kits, pre-clinical therapeutics, and qPCR design, aiding genomic research and analysis.
- Headquarters Petaluma, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biosearchtech.com
- Social LinkedIn X Facebook
- Legal Name Lucigen Corp
- Latest Funding Round$225K (USD), Grant
Jun 2016
- InvestorsHHS
& 2 more
- Investments & Acquisitions
Products & Services of LGC Biosearch Technologies
LGC Biosearch Technologies offers a comprehensive portfolio of products and services, including Oligos, KASP Genotyping Reagents, PCR Instruments, and Nucleic Acid Extraction Kits.
Custom synthesized oligonucleotides for genetic research applications
Reagents for qPCR-based SNP genotyping assays
Devices for polymerase chain reaction and DNA amplification
Kits for purifying DNA and RNA from biological samples
Funding Insights of LGC Biosearch Technologies
- Total Rounds 33
- Last Round Grant — $224,997
- First Round $1.98M
(Jun 2006)
- Investors Count 3
Latest 10 of 33 funding rounds of LGC Biosearch Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $224,997 | Grant | – | – | |
| Jun 2015 | $1.35M | Grant | – | – | |
| Jun 2014 | $979,171 | Grant | – | – | |
| Apr 2014 | $158,809 | Grant | – | – | |
| Jun 2013 | $450,930 | Grant | – | – | |
| Jun 2012 | $4.04M | Grant | – | – | |
| May 2012 | $2.69M | Grant | – | – | |
| May 2012 | $158,809 | Grant | – | – | |
| Aug 2011 | $199,185 | Grant | – | – | |
| Jun 2011 | $150,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in LGC Biosearch Technologies
LGC Biosearch Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, OSTI.GOV and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Scientific and technical information is managed and disseminated by OSTI.GOV. | – | osti.gov | Oak Ridge, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for LGC Biosearch Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LGC Biosearch Technologies
3 people are tracked at LGC Biosearch Technologies (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Tim Robinson | CEO | Leadership |
Troy Ullman | Director Of Finance | Leadership |
Devon Calonge | Finance Manager | Team |
Complete people profiles for LGC Biosearch Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LGC Biosearch Technologies
LGC Biosearch Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lightspeed Genomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Using proprietary optical imaging technology to develop DNA sequencing platform. | lsgen.com | Santa Clara, United States | 2006 | Sep 2013 | •••• |
Complete acquisition details for LGC Biosearch Technologies
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LGC Biosearch Technologies
4 dated milestones of LGC Biosearch Technologies across 23 years, from founding to its latest funding, stage changes and deals.
- Founded LGC Biosearch Technologies is founded.
- Funding First funding round of $2.0M.
- Acquisition Acquires Lightspeed Genomics.
- Funding Latest funding round, Grant, of $225K.
Competitors of LGC Biosearch Technologies
LGC Biosearch Technologies has 10 listed competitors in our database, 7 of them funded. They include ArcherDX, NuProbe, Nanosphere, ThunderBio Innovation and Gen-Probe, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| nuprobe.com | 2016 | George Town, Cayman Islands | $61M | – | Sensitive multiplex platforms for QPCR are developed using toehold probes. | |
| nanosphere.us | 1999 | Northbrook, United States | $97.75M | 146 | Diagnostic tests for personalized medicine targeting infections are provided. | |
| thunder-bio.com | 2018 | Jiaxing, China | $15.47M | – | Microfluidic technology is developed for diagnostic and research applications. | |
| gen-probe.com | 1996 | San Diego, United States | – | – | Provides clinical diagnostics, blood screening, and research products. | |
| twt.com | 1993 | Xiamen, China | $19.3M | – | Molecular diagnostic devices and reagents are developed and marketed. | |
| kiomedpharma.com | 2012 | Herstal, Belgium | $6.73M | 20 | Bio-polymer chitosan products are developed for medical uses. | |
| tymora-analytical.com | 2010 | Lafayette, United States | – | – | Laboratory technologies for protein research are developed and supplied. | |
| dhiusa.com | 1983 | Athens, United States | $10M | 1,103 | Molecular diagnostic kits for infectious diseases are developed and manufactured. | |
| innosieve.com | 2007 | Wageningen, Netherlands | – | – | Microbial diagnostic test kits are provided for contamination analysis. |
Detailed competitors of LGC Biosearch Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LGC Biosearch Technologies
The website of LGC Biosearch Technologies (biosearchtech.com) receives about 52K visits a month.
- Monthly visits52K
▲ 1.9% vs previous month
Websites whose visitors overlap most with LGC Biosearch Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qiagen.com | 100% | 458.2K | #105,023 | View details | |
| bio-rad.com | 92% | 665.2K | #79,666 | View details | |
| idtdna.com | 90% | 505.8K | #85,096 | View details | |
| genelink.com | 84% | 10.8K | #2,265,843 | View details | |
newenglandpeptide.com | newenglandpeptide.com | 76% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for LGC Biosearch Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as LGC Biosearch Technologies (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lgc Biosearch Technologies
Complete news archive for LGC Biosearch Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LGC Biosearch Technologies
LGC Biosearch Technologies was founded in 1993 and raised its 1st funding round 13 years after it was founded.
LGC Biosearch Technologies is headquartered in Petaluma, United States. It is registered at Petaluma, California, United States.
LGC Biosearch Technologies was founded in 1993 and is headquartered in Petaluma, United States. Operations focus on the biotechnology sector, where kits and reagents for qPCR, SNP genotyping via dual-labeled probes, molecular beacons, scorpion primers, and calibration dyes are developed. Oligo synthesis and RNA FISH capabilities are also supported. Services encompass GMP manufacturing, custom kits, pre-clinical therapeutics, and qPCR design, aiding genomic research and analysis.
LGC Biosearch Technologies's top competitors include ArcherDX, NuProbe and Nanosphere.
LGC Biosearch Technologies offers Oligos, KASP Genotyping Reagents, PCR Instruments, and Nucleic Acid Extraction Kits.
LGC Biosearch Technologies has made 1 acquisition, including Lightspeed Genomics.
LGC Biosearch Technologies has 3 investors. Key investors include HHS, OSTI.GOV, and National Science Foundation.
LGC Biosearch Technologies operates through Lucigen Corp.